Chinese Journal of Pharmacovigilance ›› 2019, Vol. 16 ›› Issue (4): 246-247.
Previous Articles Next Articles
LI Wenling1, JIN Wei2, CHEN Bohua1, XU Beiming3,*
Received:2019-05-09
Revised:2019-05-09
Online:2019-04-20
Published:2019-05-09
CLC Number:
LI Wenling, JIN Wei, CHEN Bohua, XU Beiming. One Case of Cellulitis Induced by Pramipexole Hydrochloride Tablets[J]. Chinese Journal of Pharmacovigilance, 2019, 16(4): 246-247.
| [1] 中华医学会神经病学分会. 帕金森病及运动障碍学组中国帕金森病治疗指南 (第三版)[J]. 中华神经科杂志,2014,47(6):428-433. [2] 李珉,宋淦. 盐酸普拉克索速释片与多巴丝肼片治疗帕金森病的临床效果及安全性评价[J]. 中外医学研究,2018,16(8):28-30. [3] 何浩,杨文明,王晓,等. MicroRNA-7在帕金森病中的作用及研究进展[J]. 安徽医药,2018,22(4):599-602. [4] 杨晓鲲,徐明元,范云飞,等. 一种预测下肢蜂窝组织炎的新评分表[J]. 西南国防医药,2018,28(3):277-280. [5] 唐洁,刘智慧,洪慧丰. 金刚烷胺致下肢水肿、幻觉及睡眠、排尿障碍1例[J]. 中国冶金工业医学杂志,2016,33(4):375. [6] 上海勃林格殷格翰药业有限公司. 盐酸普拉克索(森福罗)药品说明书[S]. 2011. [7] Zavala J A, Munhoz R P, Teive H A .Pramipexole-related chronic lower limb oedema in a patient with Parkinson's disease[J]. Journal of Clinical Neuroscience, 2012, 19(9):1298-1299. [8] Biglan K M, Holloway R G, Mcdermott M P, et al.Risk factors for somnolence, edema, and hallucinations in early Parkinson disease[J]. Neurology, 2007, 69(2):187-195. [9] Tan E K, Ondo W .Clinical Characteristics of Pramipexole-Induced Peripheral Edema[J]. Archives of Neurology, 2000, 57(5):729. [10] 范景辉,李海燕,周扬. 1例帕金森伴异动症患者口服普拉克索致双下肢水肿的病例分析[J]. 继续医学教育,2015,29(7):114-115. [11] Cicero C E, Nicoletti A, Mostile G, et al.A case of severe leg oedema in a patient with Parkinson's disease treated with pramipexole[J]. Postgraduate Medical Journal, 2016, 92(1090):484-484. [12] Kleiner-Fisman G, Fisman D N .Risk Factors for the Development of Pedal Edema in Patients Using Pramipexole[J]. Archives of Neurology, 2007, 64(6):820-824. |
| [1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
| [2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
| [3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
| [4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
| [5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
| [6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
| [7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
| [8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
| [9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
| [10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
| [11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
| [12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
| [13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
| [14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
| [15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
